PuSH - HMGU Publikationen https://push-zb.helmholtz-munich.de PuSH - Publikationen-Server des Helmholtz Zentrums München de-de <![CDATA[Senz, A.M.* et al. RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. J. Immunother. Cancer 14:e013282 (2026)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=76696&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=76696&la=de Wed, 11 Mar 2026 00:00:00 +0000 <![CDATA[Andreu-Sanz, D.* et al. Predictive value of preclinical models for CAR-T cell therapy clinical trials: A systematic review and meta-analysis. J. Immunother. Cancer 13:e011698 (2025)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=74928&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=74928&la=de Tue, 17 Jun 2025 00:00:00 +0000 <![CDATA[Chen, W.L.* et al. Differential regulation of calcium-NFAT signaling pathway by Akt isoforms: Unraveling effector dynamics and exhaustion of cytotoxic T lymphocytes in tumor microenvironment. J. Immunother. Cancer 13:e009827 (2025)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=73785&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=73785&la=de Fri, 09 May 2025 00:00:00 +0000 <![CDATA[Märkl, F.* et al. Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma. J. Immunother. Cancer 11:14 (2023)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=67915&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=67915&la=de Fri, 06 Oct 2023 00:00:00 +0000 <![CDATA[Gottschlich, A.* et al. Single-cell transcriptomic atlas-guided development of chimeric antigen-receptor (CAR) T cells for the treatment of acute myeloid leukemia. J. Immunother. Cancer 10, A31-A31 (2022)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66969&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66969&la=de Fri, 13 Jan 2023 00:00:00 +0000 <![CDATA[Mempel, T.R.* & Krappmann, D. Combining precision oncology and immunotherapy by targeting the MALT1 protease. J. Immunother. Cancer 10:e005442 (2022)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66468&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66468&la=de Tue, 25 Oct 2022 00:00:00 +0000 <![CDATA[Stock, S.* et al. Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors. J. Immunother. Cancer 10:e005054 (2022)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=65850&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=65850&la=de Tue, 08 Nov 2022 00:00:00 +0000 <![CDATA[Ahmetlic, F. et al. Therapy of lymphoma by immune checkpoint inhibitors: The role of T cells, NK cells and cytokine-induced tumor senescence. J. Immunother. Cancer 9:e001660 (2021)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=61018&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=61018&la=de Fri, 26 Mar 2021 00:00:00 +0000 <![CDATA[Keller, P.* et al. Reprogramming regulatory T cells (TREG) using a MALT1 inhibitor for cancer therapy. J. Immunother. Cancer 9, A902-A902 (2021)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64768&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64768&la=de Mon, 09 May 2022 00:00:00 +0000 <![CDATA[Baroni, M.L.* et al. 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo. J. Immunother. Cancer 8:e000845 (2020)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59357&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59357&la=de Tue, 16 Jun 2020 00:00:00 +0000 <![CDATA[Bauer, V. ; Ahmetlic, F. ; Roecken, M.* & Mocikat, R. Immune checkpoint blockade impacts the suppressive phenotype and function of regulatory T cells in an endogenous mouse lymphoma model. J. Immunother. Cancer 8, 3, A467-A468 (2020)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=60190&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=60190&la=de Tue, 06 Oct 2020 00:00:00 +0000 <![CDATA[Gambichler, T.* ; Reuther, J.* ; Scheel, C. & Becker, J.C.* On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19. J. Immunother. Cancer 8:e001145 (2020)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59578&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59578&la=de Tue, 07 Jul 2020 00:00:00 +0000 <![CDATA[Yanchun, M. et al. Interleukin-10 drives the development of T regulatory type 1 (Tr1) cells and is a target for immunotherapy. J. Immunother. Cancer 8, 3, A500 (2020)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=60189&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=60189&la=de Thu, 04 Mar 2021 00:00:00 +0000 <![CDATA[Kuczek, D.E.* et al. Collagen density regulates the activity of tumor-infiltrating T cells. J. Immunother. Cancer 7:68 (2019)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=55686&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=55686&la=de Fri, 29 Mar 2019 00:00:00 +0000